ELCC 2019 | Treatment sequecing strategies in advanced NSCLC
Martin Reck
Martin Reck, MD, PhD, from Lung Clinic Grosshansdorf, Grosshansdorf, Germany, explains recent changes and sequencing strategies in non-mutated, non-squamous advanced non-small cell lung cancer (NSCLC). This interview took place at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.
Related videos
2:03
TKIs to treat EGFRm-positive NSCLC
Marina Garassino
1:16
The promise of stereotactic radiotherapy for oligometastases
Françoise Mornex
1:50
Prof. Kelly’s overview of the RECaN project
Daniel Kelly
1:03
Managing oligometastatic NSCLC with thoracic irradiation
Françoise Mornex
2:06
Afatinib for advanced EGFRm-positive NSCLC
Antonio Passaro
